incidence of primary malignant bone tumours as a whole, and of their age and sex distribution, can be obtained from the figures for bone tumour mortality for England and Wales (Mackenzie et al. 1961 , Boyd et al. 1969 ). Bone tumour mortality -and presumably incidence -is higher in males than in females at almost all ages: it shows a peak at about [15] [16] [17] [18] [19] [20] In recent years a number of patients with arthritis affecting the knee-joint have been treated by means of osteoarticular allografts which replace the articular surfaces of the knee-joint (Laurence 1969) . We are at present engaged in a study of the osteoarticular allograft in the sheep. This paper deals with the immunological aspects of this problem.
It has been found that sheep receiving articular allografts to the femoral condyles will develop cytotoxic antibodies which can be demonstrated in their serum. These antibodies increase rapidly in their spectrum of multispecificity from within one or two weeks of grafting. A number of experimental sheep had pre-existing antileukocyte antibodies before grafting. These antibodies were probably due to immunization by pregnancy, as serum from rams and 3-month-old lambs had no cytotoxic effects. In 10 out of 11 sheep with pre-existing cytotoxic antibodies, grafting resulted in a very much more rapid increase in the degree of multispecificity than in sheep without these antibodies. These findings suggest the need for cross-matching for leukocyte antibodies before osteoarticular allografting.
The grafts used in these sheep consisted of articular cartilage, bone and bone marrow. Experiments were performed using grafts from sheep, and rats as recipients. These clearly demonstrated that the immunogenicity of the composite graft resides in the bony fraction and in all probability is due to the presence of bone marrow.
Pure articular cartilage elicited a weak antibody response in only 1 out of 11 rats. The chondrocyte does possess major transplantation antigens. This was demonstrated by comparing the effect of antileukocyte isoantibodies on chondrocytes, isolated from their matrix, with that on lymphocytes from the same donor sheep using a fluorochromatic lymphocytotoxicity test. This experiment also demonstrated the protective natwe of the cartilage matrix.
Finally, a new in vitro system which allows a study of the effect of cytotoxic antibody upon intact articular cartilage has shown that the antibody can diffuse through the cartilage matrix and in the presence of complement will bring about a reduction of the metabolic activity (? cell death) of chondrocytes as revealed by a lack of 3-S uptake.
These findings clearly indicate that the osteoarticular graft cannot be regarded as immunologically inert or privileged. They show that an immune response is initiated by the antigens of the bony aspect of the graft, leading to the production of circulating antibodies which can bring about the death of the cartilage cells and so may hasten the breakdown of the graft. Preliminary studies indicate that this is true also of the human osteoarticular graft. It is suggested that before this procedure is attempted in the human subject tissue-typing of donor and recipient should be carried out to minimize the degree of antigenic disparity. (Weissmann et al. 1965) . These changes were thought to be produced by the release of injurious lysosomal hydrolases by the hemolysin which is known to release enzymes from isolated lysosomes (Weissmann et al. 1963) . Although the changes produced by intra-articular injections of the toxin have been confirmed in this department, no evidence suggesting lysosomal enzyme release was found (Cook & Fincham 1966) .
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